Sort
15,842 grants matching “pancreatic cancer”
NEUROGENIC AMPLIFICATION OF PANCREATITIS PAIN
$298,000University Of Texas Medical Br Galveston · R01 · FY2003 · NS
NEUROGENIC AMPLIFICATION OF PANCREATITIS PAIN
$298,000University Of Texas Medical Br Galveston · R01 · FY2002 · NS
NEUROGENIC AMPLIFICATION OF PANCREATITIS PAIN
$298,000University Of Texas Medical Br Galveston · R01 · FY2001 · NS
Gli Activity in the Pancreas: Inflammation, Tissue Repair and Cancer
$297,970Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2010 · CA
Formation and Resolution of Recombination Intermediates
$297,900Patrick Sung · Yale University · R01 · FY2009 · GM
Formation and Resolution of Recombination Intermediates
$297,900Patrick Sung · Yale University · R01 · FY2008 · GM
MicroRNA-1291 in Regulation of Xenobiotic Disposition and Cell Differentiation
$297,890Aiming Yu · University Of California At Davis · U01 · FY2018 · CA
Amplification of tumor hypoxic responses by MIF-dependent HIF stabilization
$297,887Robert A. Mitchell · University Of Louisville · R01 · FY2012 · CA
Targeting Ras-Ral GEF-Ral Effector Signaling for Pancreatic Cancer Treatment
$297,887Jen Jen Yeh · Univ Of North Carolina Chapel Hill · R01 · FY2012 · CA
Targeting Ras-Ral GEF-Ral Effector Signaling for Pancreatic Cancer Treatment
$297,887Jen Jen Yeh · Univ Of North Carolina Chapel Hill · R01 · FY2011 · CA
Amplification of tumor hypoxic responses by MIF-dependent HIF stabilization
$297,887Robert A. Mitchell · University Of Louisville · R01 · FY2011 · CA
Pancreatic Ductal Adenocarcinoma Targeted Ultrasound Contrast Agent Development
$297,786Evan Charles Unger · Nuvox Pharma, Llc · R41 · FY2016 · CA
Development of a Novel High-Throughput Screening Platform for BK Channel Modulato
$297,768Frank T Horrigan · Baylor College Of Medicine · R01 · FY2014 · GM
Development Control in C. elegans
$297,766Min Han · University Of Colorado · R01 · FY2019 · GM
SIAH2-Dependent Proteolysis in Cell Migration, Tumor Growth and Cancer Metastasis
$297,763Amy H. Tang · Eastern Virginia Medical School · R01 · FY2010 · CA
Ras-mediated signals in human epithelial cell transformation and metastasis
$297,751Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
RON Receptor in Pancreatic Cancer Biology and Therapy
$297,734Andrew M Lowy · University Of California, San Diego · R01 · FY2019 · CA
Molecular Markers for the Diagnosis of Pancreatic Cancer
$297,686Surinder Kumar Batra · University Of Nebraska Medical Center · R01 · FY2011 · CA
Molecular Markers for the Diagnosis of Pancreatic Cancer
$297,686Surinder Kumar Batra · University Of Nebraska Medical Center · R01 · FY2012 · CA
Survival Mechanisms of Invasive Carcinoma Cells
$297,592Richard L. Klemke · University Of California, San Diego · R01 · FY2010 · CA
Mechanisms of immunomodulation with epigenetic therapy
$297,559Nilofer S. Azad · Johns Hopkins University · P01 · FY2024 · CA
Novel MAP Kinase Pathway Inhibitors to Treat Pancreatic Ductal AdenoCarcinoma
$297,555Deborah Slee · Kalyra Pharmaceuticals, Inc. · R44 · FY2016 · CA
Disrupting Protein-Protein Interactions With Bis-peptides
$297,520Christian E Schafmeister · Temple Univ Of The Commonwealth · R01 · FY2012 · GM
Basic Science Research in Digestive Diseases
$297,519Mark Donowitz · Johns Hopkins University · T32 · FY2017 · DK
AKT2 FUNCTION AND ONCOGENIC ACTIVITY
$297,470Fox Chase Cancer Center · R01 · FY2000 · CA